Both in Pharmaceuticals
Latigo Biotherapeutics vs Alto Neuroscience
Over the past year LTGO returned −38.1% and ANRO returned −31.6%; their daily moves had a correlation of 0.32.
LTGO −38.1% ANRO −31.6%Growth of $1, one year, split-adjusted
| Metric | LTGO | ANRO |
|---|---|---|
| Price | $13.72 | $21.88 |
| Market cap | $909.3M | $858.6M |
| Today | −1.68% | −3.19% |
| 1 month | −13.7% | −11.8% |
| 6 months | — | −13.1% |
| Year to date | — | +22.9% |
| 1 year | — | +52.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | $225.1M |
| Dividend yield | — | — |
| Volatility (60d) | — | 56.3% |
| Short % of float | 1.6% | 20.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).